G H Olafsdottir
Overview
Explore the profile of G H Olafsdottir including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
213
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Stefansdottir V, Skirton H, Johannsson O, Olafsdottir H, Olafsdottir G, Tryggvadottir L, et al.
Fam Cancer
. 2018 Sep;
18(2):153-160.
PMID: 30251169
A comprehensive pedigree, usually provided by the counselee and verified by medical records, is essential for risk assessment in cancer genetic counseling. Collecting the relevant information is time-consuming and sometimes...
2.
Gabe R, Tryggvadottir L, Sigfusson B, Olafsdottir G, Sigurdsson K, Duffy S
Acta Radiol
. 2007 Dec;
48(9):948-55.
PMID: 18080359
Background: The Icelandic breast cancer screening program, initiated November 1987 in Reykjavik and covering the whole country from December 1989, comprises biennial invitation to mammography for women aged 40-69 years...
3.
Tulinius H, Olafsdottir G, Sigvaldason H, Arason A, Barkardottir R, Egilsson V, et al.
J Med Genet
. 2002 Jul;
39(7):457-62.
PMID: 12114473
Objective: To estimate the risk of malignant diseases in families of probands with the same mutation in the BRCA2 gene. Design: A cohort study using record linkage of a breast...
4.
Winther J, Sankila R, Boice J, Tulinius H, Bautz A, Barlow L, et al.
Lancet
. 2001 Sep;
358(9283):711-7.
PMID: 11551577
Background: In some rare inherited disorders such as Li-Fraumeni syndrome, relatives of children with cancer are at increased risk of cancer. We aimed to assess relations between childhood cancer and...
5.
Gretarsdottir S, Olafsdottir G, Borg A
Hum Mutat
. 2000 Jan;
12(3):212.
PMID: 10651484
Germ-line mutations in the p16/CDKN2 gene are known to predispose to melanoma. This gene belongs to a family of cyclin-dependent kinase inhibitors and blocks G1-S progression. The occurrence of p16/CDKN2...
6.
Huiping C, Johannsdottir J, Arason A, Olafsdottir G, Eiriksdottir G, Egilsson V, et al.
Oncol Rep
. 1998 Dec;
6(1):117-22.
PMID: 9864413
Replication errors (RER) at microsatellite repeats indicate genomic instability in hereditary nonpolyposis colorectal cancer (HNPCC) and in some sporadic cancers. We have studied genomic instability in 313 sporadic breast tumors...
7.
Thorlacius S, Struewing J, Hartge P, Olafsdottir G, Sigvaldason H, Tryggvadottir L, et al.
Lancet
. 1998 Nov;
352(9137):1337-9.
PMID: 9802270
Background: Estimates of an 80-90% risk of breast cancer for carriers of germline mutations in the BRCA1 and BRCA2 genes are based on studies of families at high risk of...
8.
Thorlacius S, Tryggvadottir L, Olafsdottir G, Jonasson J, Ogmundsdottir H, Tulinius H, et al.
Lancet
. 1995 Aug;
346(8974):544-5.
PMID: 7658781
Breast cancer is rare in men, and family history of the disease is a risk factor. The recently discovered BRCA2 gene on chromosome 13q is thought to account for some...
9.
Tulinius H, Olafsdottir G, Sigvaldason H, Tryggvadottir L, Bjarnadottir K
J Med Genet
. 1994 Aug;
31(8):618-21.
PMID: 7815419
Objective: To investigate whether the risk of cancer at all sites, and at individual sites other than breast, prostate, ovaries, and endometrium, is increased among relatives of breast cancer patients...
10.
Tulinius H, Egilsson V, Olafsdottir G, Sigvaldason H
BMJ
. 1992 Oct;
305(6858):855-7.
PMID: 1422397
Objective: To investigate the risk of prostate, ovarian, and endometrial cancer among relatives of patients with breast cancer. Design: Cohort study of 947 pedigrees in which the proband had breast...